Icon reports record $605m in new business

Dublin-based clinical trials group reports strong third-quarter earnings

Icon  employs more than 12,000 staff worldwide, including more than 1,000 in Dublin and Limerick

Icon employs more than 12,000 staff worldwide, including more than 1,000 in Dublin and Limerick

 

Dublin-based and Nasdaq-listed clinical trials group Icon has reported a record $605 million in new business for the third quarter. Reported income from operations in the quarter was $97.9 million or 15 per cent of revenue.

The Irish group, which currently employs over 12,000 staff worldwide - including more than 1,000 in Dublin and Limerick, said revenue grew over 8 per cent to $476 million compared to the same quarter last year and earnings per share increased by 15 per cent to $1.55. Year-to-date reported revenue was $1.9 billion, the company said.

“Quarter 3 was another strong quarter for Icon,”chief executive Steve Cutler said, noting the company’s record net business wins. “As a result, I am very pleased with our continued ability to execute our strategic plans which position us well for sustainable revenue and EPS growth,” he said.